Endpoint definition
↥Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule
Extra metadata
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule
Extra metadata
List of similar endpoints to Vulvovaginal ulceration/inflammation in other diseases based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 789 | 789 | - |
Unadjusted prevalence (%) | 0.30 | 0.54 | - |
Mean age at first event (years) | 36.80 | 36.80 | - |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.03 | 1.75 [0.46, 6.61] | 4.1e-1 | 12 |
15 years | 0.02 | 2.71 [0.84, 8.78] | 9.6e-2 | 11 |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: N14_VULVOVAGINFINOTH – Vulvovaginal ulceration/inflammation in other diseases
GWS hits: 1
before Vulvovaginal ulceration/inflammation in other diseases
after Vulvovaginal ulceration/inflammation in other diseases
Loading survival analyses plot
Loading survival analyses table